Tourbah, A., Lebrun-Frenay, C., Edan, G., Clanet, M., Papeix, C., Vukusic, S., . . . Pelletier, J. (2016). MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study. Mult Scler.
Chicago Style CitationTourbah, Ayman, et al. "MD1003 (high-dose Biotin) for the Treatment of Progressive Multiple Sclerosis: A Randomised, Double-blind, Placebo-controlled Study." Mult Scler 2016.
MLA CitationTourbah, Ayman, et al. "MD1003 (high-dose Biotin) for the Treatment of Progressive Multiple Sclerosis: A Randomised, Double-blind, Placebo-controlled Study." Mult Scler 2016.
Warning: These citations may not always be 100% accurate.